These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26411737)

  • 1. Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report.
    Malahleha M; Ahmed K; Deese J; Nanda K; van Damme L; De Baetselier I; Burnett RJ
    J Med Case Rep; 2015 Sep; 9():207. PubMed ID: 26411737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
    Solomon MM; Schechter M; Liu AY; McMahan VM; Guanira JV; Hance RJ; Chariyalertsak S; Mayer KH; Grant RM;
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):281-6. PubMed ID: 26413853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
    Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN
    Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.
    Trang TP; Dong BJ; Kojima N; Klausner JD
    Expert Opin Drug Saf; 2016 Sep; 15(9):1287-94. PubMed ID: 27391203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.
    Adams JL; Shelley K; Nicol MR
    Pharmacotherapy; 2019 Apr; 39(4):486-500. PubMed ID: 30815960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa.
    Naicker CL; Mansoor LE; Dawood H; Naidoo K; Singo D; Matten D; Williamson C; Abdool Karim Q
    BMC Infect Dis; 2020 Jul; 20(1):532. PubMed ID: 32698772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOVING FORWARD WITH PrEP. THE BASICS OF PrEP.
    Highleyman L
    Posit Aware; 2015; 27(5):2-3. PubMed ID: 26714333
    [No Abstract]   [Full Text] [Related]  

  • 8. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.
    Dolling DI; Desai M; McOwan A; Gilson R; Clarke A; Fisher M; Schembri G; Sullivan AK; Mackie N; Reeves I; Portman M; Saunders J; Fox J; Bayley J; Brady M; Bowman C; Lacey CJ; Taylor S; White D; Antonucci S; Gafos M; McCormack S; Gill ON; Dunn DT; Nardone A;
    Trials; 2016 Mar; 17():163. PubMed ID: 27013513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Antiretroviral Pre-Exposure Prophylaxis: Development Challenges and Pipeline Promise.
    Hendrix CW
    Clin Pharmacol Ther; 2018 Dec; 104(6):1082-1097. PubMed ID: 30199098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to do it: setting up a PrEP service in an integrated sexual reproductive health service setting.
    Knapper C; Birley H; Couzens Z; Jones AT; Parker I
    Sex Transm Infect; 2018 Aug; 94(5):327-330. PubMed ID: 29950377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The difficulties of managing severe hepatitis B virus reactivation.
    Roche B; Samuel D
    Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out.
    Joseph Davey D; Hsiao NY; Wendy Spearman C; Sonderup M; Hu NC; Mashele N; Mvududu R; Myer L
    BMC Infect Dis; 2022 Sep; 22(1):719. PubMed ID: 36050648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOW DO I PAY FOR PrEP?
    Evans D
    Posit Aware; 2015; 27(5):18-9. PubMed ID: 26714339
    [No Abstract]   [Full Text] [Related]  

  • 14. A case study of chewed Truvada
    Lalley-Chareczko L; Clark D; Zuppa AF; Moorthy G; Conyngham C; Mounzer K; Koenig H
    Antivir Ther; 2017; 22(7):639-641. PubMed ID: 28260694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truvada (emtricitabine/tenofovir) pre-exposure prophylaxis roll-out among South African university students: Lots of positives, but let us keep an eye on possible surprises.
    Montjane K; Dlamini S; Dandara C
    S Afr Med J; 2018 Feb; 108(2):79-81. PubMed ID: 29429434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis.
    Radzio J; Henning T; Jenkins L; Ellis S; Farshy C; Phillips C; Holder A; Kuklenyik S; Dinh C; Hanson D; McNicholl J; Heneine W; Papp J; Kersh EN; García-Lerma JG
    J Infect Dis; 2016 May; 213(10):1541-5. PubMed ID: 26743846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".
    Calabrese SK; Underhill K
    Am J Public Health; 2015 Oct; 105(10):1960-4. PubMed ID: 26270298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW; Coyle L; Jones BE; Pattullo V
    Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.